Tarsus Pharmaceuticals, Inc. has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment of Ocular Rosacea, a significant but currently ...

eye drops may be used to manage symptoms associated with mild ocular rosacea. The fastest-acting treatment for rosacea typically involves topical vasoconstrictors at low doses, such as Mirvaso ...

This type of rosacea may occur alone or with ETR type. Common treatments for PPR include: Ocular rosacea affects your eyes and causes eye swelling, redness, dryness, itching, and burning.

Moreover, Tarsus is extending its reach into ocular rosacea, a condition with no FDA-approved treatments, by advancing TP-04 into a Phase 2 study. The potential for TP-04 to address a significant ...

“That study needs some validation, but I think it’s something to keep an eye on,” Gallo said. What remains unclear, he continued, is exactly why rosacea causes increased sensitivity of ...

The commentary focused on Tarsus Pharmaceuticals' impressive sales figures for their product XDEMVY, particularly highlighting its potential in treating ocular rosacea. The company has demonstrated ...

State Medicaid formularies demonstrate significant variability in rosacea treatment coverage, with only 10% of states offering unrestricted access to basic therapeutic options, in an analysis of ...

The commentary focused on Tarsus Pharmaceuticals' impressive sales figures for their product XDEMVY, particularly highlighting its potential in treating ocular rosacea. The company has ...